Efficacy of Satralizumab As Monotherapy in Pre-Specified Subgroups of Sakurastar, a Double-Blind Placebo-Controlled Phase 3 Clinical Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Category Primary study
JournalMultiple Sclerosis and Related Disorders
Year 2020
This article has no abstract
Epistemonikos ID: 7dc46313bdf754d6948c44957bf601f06bb1c10d
First added on: Feb 11, 2025